oral semaglutide weight loss side effects Berkshire Now that oral semaglutide (#wegovy)

Purpose-built for physicians The changing landscape of endocrinology: GLP-1s, new diabetes technology and more The field of endocrinology saw many advancements in 2024 and more developments and innovations are anticipated in 2025

they work better as a team

NRF1 is a transcription factor that belongs to the same transcription factor family as NRF2

Ideal for energy balance, weight regulation, and peptide-based metabolic modulation research

The cardiovascular outcome trials and studies in people with renal disease and heart failure confirm significant benefits in these comorbidities, which appear to be independent of glucose lowering, with the HF and CKD benefits demonstrated in people with and without T2DM